Find The Best Stocks With Perfect Trade Setups In Minutes A Day

Stop wasting time looking for the right stocks.  Free training on how to find perfect stock trades that can move 300-1,500%.  Learn the # 1 key to successful stock investing and how to find success even If the market is crashing, rebounding… or just going sideways. (ad)

Do Not Delay - Click Here Now


5 of the Most Volatile Stocks on the Market Right Now

Every investor knows that volatility can strike at any time due to a variety of economic and geopolitical factors. Market participants saw that last month when the S&P 500 nosedived 6.6% in its worst May performance since 2012 and second-worst since the 1960s. But overall market volatility is hardly important without pinning it against individual stock volatility, and that’s exactly why the beta metric is so important to consider when picking stocks.

Beta measures how much an individual stock responds to volatility in the broader market indexes. It helps investors understand whether a stock moves in the same direction as the rest of the market and how volatile or risky it is compared to the market. A beta of 1.0 means a stock moves mostly in lockstep with the market. If the beta is less than 1.0, it’s less volatile than the broader market, while a beta greater than 1.0 indicates it’s more volatile. For instance, if a stock has a beta of 1.4, it’s assumed to be 40% more volatile than the broader market.

All of this makes sense when considering how stocks with the highest betas are often either in historically volatile sectors or trade at low share prices. Most of the firms on the list are small caps, with the majority being in the highly volatile pharmaceutical and biotech sectors.

Here are five of the most volatile stocks on the Nasdaq and New York Stock Exchange (NYSE), ranked by average monthly beta over the last three years…

No. 5: Blink Charging Co. (BLNK)

Blink is an electric vehicle (EV) company primarily providing EV charging equipment that drivers use to recharge at various locations. The firm also offers a cloud-based software called Blink Network, which operates and tracks Blink’s charging stations and associated charging data, as well as enables property owners, managers, and parking companies to remote monitor and manage their EV charging stations and payment processing. 

Shares of BLNK have traded under $10 since late 2017, making the stock more susceptible to huge percentage swings. As of Tuesday, June 11, BLNK has a beta of 5.36 and is therefore about 536% more volatile than the broader market. Shares are up more than 52% this year from $1.72 to $2.62 but are down roughly that same percentage from $5.46 over the last 12 months.

No. 4: Zynerba Pharmaceuticals Inc. (ZYNE)

The least volatile pharma company on the list is Zynerba, which develops cannabinoid-based treatments for rare psychiatric disorders like Fragile X syndrome (FXS) and autism spectrum disorders (ASDs) that affect children and adolescents. The company’s highest profile treatment is Zygel, the first and only pharmaceutically produced cannabidiol (CBD) treatment that’s currently in Phase 2 clinical trials.

ZYNE has seen wild swings in the last six months, going from a low of $2.89 per share on Dec. 21 all the way to a high of $15.50 on May 16. It has a beta of 5.45 and is up a whopping 354.5% year-to-date, gaining nearly 17% during Tuesday’s session alone.

No. 3: Pier 1 Imports Inc. (PIR)

Pier 1 is a retail chain that sells furniture, housewares, gifts, and seasonal products. As of the first quarter, there are roughly 973 Pier 1 locations in the United States and 75 locations in Canada. The company is also one of the oldest publicly traded retail companies in the country, launching its IPO in 1970 and joining the NYSE in 1972.

With a more than 135% gain in 2019, PIR is one of the year’s top-performing retail stocks. However, shares have swung wildly this year from a low of $0.31 all the way to a high of $1.42. The stock has a beta of 6.08, which is more than more than six times the general retail sector’s average beta of 0.91 as of January.

No. 2: PLx Pharma Inc. (PLXP)

PLx is a small-cap pharma company based in Houston, Texas. The firm’s primary drug candidates are two formulations of aspirin called Vazalore – in 325 mg doses – and Vazalore – in 81 mg. These are meant to reduce acute gastrointestinal (GI) side effects as well as provide an antiplatelet – used to increase circulation – for cardiovascular disease prevention.

Shares of PLXP have surged more than 226% in 2019 from $1.53 on Dec. 31 to $5 on June 11. The stock’s beta is 6.37, starkly contrasting the industry average of 1.47 also reported in January.

No. 1: Microbot Medical Inc. (MBOT)

The stock on this list with the highest beta is Microbot Medical, which specializes in “micro-robotic” technologies used for minimally invasive surgery. These include TipCAT and ViRob, with the latter used to deliver medication to precise locations or cavities in the body. In April, the company reported it had 32 patents issued for its products and 19 pending patent applications.

Shares of MBOT stock have gained 161% this year from $1.72 to $4.49. The company has a sky-high beta of 9.49 as of June 12.

By the way, if you liked this article, you'll LOVE this Meaty free training I just published on the top 3 questions and challenges every investor faces AND how to overcome them. It's titled "10k into $2.4 Million in 18 months" and you can grab it for free here

There are risks inherent in all investments, which may make such investments unsuitable for certain persons. These include, for example, economic, political, currency exchange, rate fluctuations, and limited availability of information on international securities. You may lose all of your money trading and investing. Do NOT enter any trade without fully understanding the worst-case scenarios of that trade. And do NOT trade with money you cannot afford to lose. Past performance of an investment is not necessarily indicative of its future results. No assurance can be given that any implied recommendation will be profitable or will not be subject to losses. Information provided by the Company is not investment advice. The Company is not a registered investment adviser, stock broker, or brokerage. You agree that the Company does not represent, warrant, or take responsibility that any account will or is likely to achieve profit or losses similar to those shown. Examples published by the Company are selected for illustrative purposes only. They are not typical and do not represent the typical results of all stocks within the Company’s software or its individual scans and searches. No independent party has audited any hypothetical performance contained at this Web site, nor has any independent party undertaken to confirm that they reflect the trading method under the assumptions or conditions specified.

FREE TRADING WEBINAR - TRADERSPRO PRESENTS: Starting With Only $10,000 Retire With $2.4 Million? Click Here Now

Join Us Now